Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPAA
1876
DELISTED
Conyers Park III Acquisition Corp. Class A Common Stock
CPAA
| $18.1M | ﹤0.01% |
1,876,733
-760,137
| -29% | -$7.37M |
|
1877
CALL
Molson Coors Class B
TAP
$7.97B
| $18.1M | ﹤0.01% |
332,200
+98,300
| +42% | +$5.28M |
|
1878
PUT
Teleflex
TFX
$5.81B
| $18.1M | ﹤0.01% |
73,600
+46,600
| +173% | +$13.6M |
|
1879
The Mosaic Company
MOS
$6.87B
| $18.1M | ﹤0.01% |
382,479
+298,073
| +353% | +$18.3M |
|
1880
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
| $18M | ﹤0.01% |
+752,316
| New | +$18.2M |
|
1881
Relmada Therapeutics
RLMD
$512M
| $18M | ﹤0.01% |
947,413
+7,941
| +0.8% | +$173K |
|
1882
Kosmos Energy
KOS
$1.51B
| $18M | ﹤0.01% |
2,905,443
+1,673,526
| +136% | +$12.1M |
|
1883
Silicon Laboratories
SLAB
$7.29B
| $18M | ﹤0.01% |
128,164
+38,688
| +43% | +$5.42M |
|
1884
Chegg
CHGG
$87.5M
| $17.9M | ﹤0.01% |
955,620
+173,235
| +22% | +$3.97M |
|
1885
W.R. Berkley
WRB
$26.2B
| $17.9M | ﹤0.01% |
394,373
-386,200
| -49% | -$17.6M |
|
1886
Waldencast
WALD
$173M
| $17.9M | ﹤0.01% |
1,821,698
+72,975
| +4% | +$721K |
|
|
SPWR
1887
DELISTED
SunPower Corporation Common Stock
SPWR
| $17.9M | ﹤0.01% |
1,134,634
-303,708
| -21% | -$5.47M |
|
1888
CALL
First Citizens BancShares
FCNCA
$25.9B
| $17.9M | ﹤0.01% |
27,418
+16,470
| +150% | +$10.7M |
|
1889
PUT
Crocs
CROX
$6.32B
| $17.9M | ﹤0.01% |
367,800
-145,700
| -28% | -$8.84M |
|
1890
CALL
Conagra Brands
CAG
$7.5B
| $17.9M | ﹤0.01% |
522,700
-86,700
| -14% | -$2.95M |
|
1891
MKS Inc
MKSI
$21B
| $17.9M | ﹤0.01% |
+174,377
| New | +$20.3M |
|
1892
AES
AES
$10.5B
| $17.9M | ﹤0.01% |
851,697
+226,317
| +36% | +$4.94M |
|
1893
AGCO
AGCO
$7.1B
| $17.9M | ﹤0.01% |
181,286
+174,828
| +2,707% | +$21.8M |
|
1894
CALL
Starwood Property Trust
STWD
$6.03B
| $17.9M | ﹤0.01% |
855,100
+267,000
| +45% | +$6.14M |
|
1895
CALL
DigitalOcean
DOCN
$15.3B
| $17.9M | ﹤0.01% |
431,800
-222,400
| -34% | -$9.92M |
|
1896
SolarEdge
SEDG
$1.99B
| $17.9M | ﹤0.01% |
65,244
-61,544
| -49% | -$16.8M |
|
1897
MSC Industrial Direct
MSM
$6.91B
| $17.8M | ﹤0.01% |
237,516
+139,328
| +142% | +$11.4M |
|
|
LKFT
1898
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.8B
| $17.8M | ﹤0.01% |
319,154
+254,162
| +391% | +$15.1M |
|
1899
Warner Music
WMG
$13.4B
| $17.8M | ﹤0.01% |
730,142
+87,013
| +14% | +$2.6M |
|
1900
SL Green Realty
SLG
$3.97B
| $17.8M | ﹤0.01% |
+385,251
| New | +$24.5M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.